Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Biomedical engineer Ayse Gunduz, of the University of Florida, explain the recent developments and intricacies of deep brain stimulation. The research being developed will show health professionals just…
The frameless Deep Brain Stimulation technique was first used by Zachary T. Levine, MD, FAANS, Director of Neurosciences for Holy Cross Health, and consists of an implant that…
Approximately one-third of patients with Huntington’s disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD,…
Although there exists no reliable government database about demand for cadavers, sources like National Geographic and The Economist have reported on data compiled from individual agencies about shortages…
